erlotinib hydrochloride has been researched along with 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol) | Trials (4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol) | Recent Studies (post-2010) (4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 186 | 4 | 121 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arber, N; Kazanov, D; Pleban, S; Shapira, S; Tirosh, P | 1 |
1 other study(ies) available for erlotinib hydrochloride and 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol
| Article | Year |
|---|---|
Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cetuximab; Deoxycytidine; Erlotinib Hydrochloride; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Mice; Organoplatinum Compounds; Oxaliplatin; Tea Tree Oil; Terpenes; Xenograft Model Antitumor Assays | 2016 |